Gallstone presentation may be a missed opportunity for earlier diagnosis.
The incidence of esophageal cancer nearly doubled, and this was not due to an increase in screening.
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Tislelizumab reduced the risk of death by 30%, when compared with chemotherapy.